Published in Retrovirology on February 04, 2010
Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy. Oncogene (2010) 1.67
HTLV-1 propels thymic human T cell development in "human immune system" Rag2⁻/⁻ gamma c⁻/⁻ mice. PLoS Pathog (2011) 0.96
Lung adenocarcinoma originates from retrovirus infection of proliferating type 2 pneumocytes during pulmonary post-natal development or tissue repair. PLoS Pathog (2011) 0.89
Dual role of commensal bacteria in viral infections. Immunol Rev (2013) 0.87
Hematopoietic stem and progenitor cells as effectors in innate immunity. Bone Marrow Res (2012) 0.86
What we are learning on HTLV-1 pathogenesis from animal models. Front Microbiol (2012) 0.81
From Immunodeficiency to Humanization: The Contribution of Mouse Models to Explore HTLV-1 Leukemogenesis. Viruses (2015) 0.75
Assessment of interleukin 1β serum level in different responder groups and stages of chronic myeloid leukemia patients on imatinb mesylate therapy. Indian J Hematol Blood Transfus (2014) 0.75
Tissue architecture, feedback regulation, and resilience to viral infection. J Theor Biol (2013) 0.75
Hepatitis B Virus Replication in CD34+ Hematopoietic Stem Cells From Umbilical Cord Blood. Med Sci Monit (2016) 0.75
Stem cells, cancer, and cancer stem cells. Nature (2001) 50.27
MicroRNA signatures in human cancers. Nat Rev Cancer (2006) 46.29
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med (1997) 32.63
Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A (1980) 30.08
MicroRNAs modulate hematopoietic lineage differentiation. Science (2003) 30.05
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature (1994) 21.59
Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science (2004) 18.84
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature (2000) 16.75
Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature (2003) 14.35
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med (1997) 12.65
Cell-free transmission in adult Swiss mice of a disease having the character of a leukemia. J Exp Med (1957) 12.19
Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature (2003) 12.06
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med (2004) 11.29
Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science (2000) 10.81
TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell (1991) 10.06
Cancer stem cells. N Engl J Med (2006) 9.63
Control of apoptosis and mitotic spindle checkpoint by survivin. Nature (1998) 8.60
The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell (1990) 8.00
Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev Immunol (2002) 7.78
Stem cells and cancer; the polycomb connection. Cell (2004) 7.43
MicroRNA-cancer connection: the beginning of a new tale. Cancer Res (2006) 7.38
Physiological migration of hematopoietic stem and progenitor cells. Science (2001) 7.02
The roles of FLT3 in hematopoiesis and leukemia. Blood (2002) 6.14
Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev (1994) 6.10
p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev (1995) 5.63
MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci U S A (2005) 5.54
ASSAY FOR FRIEND LEUKEMIA VIRUS: RAPID QUANTITATIVE METHOD BASED ON ENUMERATION OF MACROSCOPIC SPLEEN FOCI IN MICE. Virology (1964) 5.51
MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood (2008) 5.23
Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J (1996) 5.17
Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E mu-myc transgenic mice. Cell (1991) 5.02
Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer (2007) 4.69
Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol (1991) 4.61
Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat Genet (2004) 4.45
The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature (1989) 4.43
MicroRNAs: key regulators of stem cells. Nat Rev Mol Cell Biol (2009) 4.26
Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci U S A (2008) 4.26
Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell (1998) 4.21
miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely. Proc Natl Acad Sci U S A (2007) 4.15
Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nat Cell Biol (1999) 4.11
Differentiation and proliferation of hematopoietic stem cells. Blood (1993) 4.02
Disruption of differentiation in human cancer: AML shows the way. Nat Rev Cancer (2003) 3.97
A common human skin tumour is caused by activating mutations in beta-catenin. Nat Genet (1999) 3.93
Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells. Blood (2001) 3.90
Cancer stem cells: lessons from leukemia. Trends Cell Biol (2005) 3.90
MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. Dev Cell (2008) 3.84
Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection. Science (1985) 3.69
Spi-1 is a putative oncogene in virally induced murine erythroleukaemias. Nature (1988) 3.59
Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity (1995) 3.51
Diversification of haematopoietic stem cells to specific lineages. Nat Rev Genet (2000) 3.42
Notch regulation of lymphocyte development and function. Nat Immunol (2004) 3.39
Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1. Immunity (2004) 3.25
Core-binding factors in haematopoiesis and leukaemia. Nat Rev Cancer (2002) 3.18
Stem cell repopulation efficiency but not pool size is governed by p27(kip1). Nat Med (2000) 3.15
Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc Natl Acad Sci U S A (1998) 3.12
Opinion: the origin of the cancer stem cell: current controversies and new insights. Nat Rev Cancer (2005) 2.89
Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I. Nat Med (2006) 2.81
Severe combined immunodeficiency (SCID) in the mouse. Pathology, reconstitution, neoplasms. Am J Pathol (1985) 2.80
Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J Gen Virol (1995) 2.66
Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome. Blood (2002) 2.66
Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. Blood (2005) 2.64
MicroRNAs as regulators of mammalian hematopoiesis. Semin Immunol (2005) 2.62
JC virus infection of hematopoietic progenitor cells, primary B lymphocytes, and tonsillar stromal cells: implications for viral latency. J Virol (1996) 2.60
Hemopoietic stem cell differentiation. Biochim Biophys Acta (1980) 2.57
Infection and replication of HIV-1 in purified progenitor cells of normal human bone marrow. Science (1988) 2.55
Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol (2001) 2.54
Leukemia and the disruption of normal hematopoiesis. Cell (1991) 2.43
Determinants of lymphoid-myeloid lineage diversification. Annu Rev Immunol (2006) 2.37
PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis. J Exp Med (2005) 2.34
HTLV-I trans-activator protein, tax, is a trans-repressor of the human beta-polymerase gene. Science (1990) 2.23
Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors. J Gen Virol (1996) 2.22
The role of microRNAs in normal hematopoiesis and hematopoietic malignancies. Leukemia (2006) 2.21
Identification of cancer stem cells in a Tax-transgenic (Tax-Tg) mouse model of adult T-cell leukemia/lymphoma. Blood (2009) 2.20
Discovery of adult T-cell leukemia. Retrovirology (2005) 2.13
Establishment of a normal hematopoietic and leukemia stem cell hierarchy. Cold Spring Harb Symp Quant Biol (2008) 2.13
Cooperating gene mutations in acute myeloid leukemia: a review of the literature. Leukemia (2008) 2.10
Life, death, and tax: role of HTLV-I oncoprotein in genetic instability and cellular transformation. J Biol Chem (2004) 2.04
The HTLV-1 Tax interactome. Retrovirology (2008) 2.02
Notch 1-deficient common lymphoid precursors adopt a B cell fate in the thymus. J Exp Med (2001) 2.02
Human immunodeficiency virus infection of bone marrow endothelium reduces induction of stromal hematopoietic growth factors. Blood (1996) 1.98
Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab Invest (1994) 1.93
beta-catenin signalling modulates proliferative potential of human epidermal keratinocytes independently of intercellular adhesion. Development (1999) 1.89
Hematopoiesis-related microRNA expression in myelodysplastic syndromes. Leuk Lymphoma (2009) 1.88
The cancer stem cell hypothesis: a work in progress. Lab Invest (2006) 1.87
Human cellular restriction factors that target HIV-1 replication. BMC Med (2009) 1.86
Stem cells in normal and leukemic hemopoiesis (Henry Stratton Lecture, 1982). Blood (1983) 1.84
Lymphocyte development from stem cells. Annu Rev Immunol (1992) 1.82
Deregulated expression of Polycomb-group oncogenes in human malignant lymphomas and epithelial tumors. Hum Mol Genet (2005) 1.79
Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia. Blood (2009) 1.79
Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood (1992) 1.76
Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human. Retrovirology (2007) 1.71
Persistent activation of NF-kappaB by the tax transforming protein of HTLV-1: hijacking cellular IkappaB kinases. Oncogene (1999) 1.68
Role of PU.1 in hematopoiesis. Stem Cells (1998) 1.66
Leukemogenesis by Moloney murine leukemia virus: a multistep process. Trends Microbiol (1997) 1.66
Human T-cell leukemia virus type I and adult T-cell leukemia. Oncogene (2003) 1.66
Spi-1/PU.1 transgenic mice develop multistep erythroleukemias. Mol Cell Biol (1996) 1.63
Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1. Cancer Res (2008) 1.63
Stage-specific expression of polycomb group genes in human bone marrow cells. Blood (1998) 1.62
Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia. Blood (1996) 1.59
Retroviruses as etiologic agents of some animal and human leukemias and lymphomas and as tools for elucidating the molecular mechanism of leukemogenesis. Blood (1982) 1.53
KSHV/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: persistence of infection during hematopoiesis in vitro and in vivo. Blood (2006) 1.37
Human T lymphotropic virus type-1 p30II alters cellular gene expression to selectively enhance signaling pathways that activate T lymphocytes. Retrovirology (2004) 1.17
Induction of cell cycle arrest by human T-cell lymphotropic virus type 1 Tax in hematopoietic progenitor (CD34+) cells: modulation of p21cip1/waf1 and p27kip1 expression. J Virol (2005) 1.13
Human T-cell lymphotropic virus type 1 p12I enhances interleukin-2 production during T-cell activation. J Virol (2003) 1.07
Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-kappa B. Blood (2002) 1.05
Human T-cell leukemia virus type 1 tax oncoprotein suppression of multilineage hematopoiesis of CD34+ cells in vitro. J Virol (2003) 1.03
Inhibition of HHV-8/KSHV infected primary effusion lymphomas in NOD/SCID mice by azidothymidine and interferon-alpha. Leuk Res (2005) 0.98
Retracted Adult T-cell leukemia/lymphoma development in HTLV-1-infected humanized SCID mice. Blood (2010) 0.97
Human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 tax oncoproteins modulate cell cycle progression and apoptosis. J Virol (2004) 0.96
Engraftment and tumorigenesis of HTLV-1 transformed T cell lines in SCID/bg and NOD/SCID mice. Leuk Res (2002) 0.89
Proinflammatory cytokine gene induction by human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 Tax in primary human glial cells. J Virol (2006) 0.89
C7a, a biphosphinic cyclopalladated compound, efficiently controls the development of a patient-derived xenograft model of adult T cell leukemia/lymphoma. Viruses (2011) 0.87
Human T lymphotropic virus type 1 accessory protein p12I modulates calcium-mediated cellular gene expression and enhances p300 expression in T lymphocytes. AIDS Res Hum Retroviruses (2005) 0.81
Retracted Human T-cell lymphotropic virus type 1 infection of CD34+ hematopoietic progenitor cells induces cell cycle arrest by modulation of p21(cip1/waf1) and survivin. Stem Cells (2008) 0.79